🔎 Trials Near Me

Akèy › Maladi otoim › Kentucky

Etid klinik pou Maladi otoim nan Kentucky

8 etid pou Maladi otoim ap chèche patisipan nan sit nan Kentucky.

Vil nan Kentucky

Tèks ofisyèl etid la (Anglè)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • University of Kentucky/Markey Cancer Center, Lexington
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • University Of Louisville Brown Cancer Center, Louisville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06722235

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Norton Cancer Institute, St. Matthews Campus, Louisville
Ap rekriteFaz 1
Laj 18 a 74 · Tout sèks · Mizajou Sep 10, 2026 · NCT07085104

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • University Of Louisville Brown Cancer Center, Louisville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06948318

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

  • Site Number - 1022, Lexington
  • Site Number - 1032, Nicholasville
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Jul 30, 2026 · NCT07039916

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • University of Louisville Hospital - James Brown Cancer Center, Louisville
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

  • University of Louisville, Louisville
Ap rekriteFaz 1
Laj 12 a 70 · Tout sèks · Mizajou May 22, 2026 · NCT06308978

VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems

  • Norton Healthcare, Louisville
  • University of Louisville, Louisville
Ap rekrite
Laj 0 a 60 · Tout sèks · Mizajou Nov 25, 2024 · NCT03953768

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.